CRTC2: CREB-Regulated Transcription Coactivator 2

A key regulator of gluconeogenesis and energy metabolism, implicated in metabolic disorders and cancer.

Gene Information Card

Symbol CRTC2
Full Name CREB regulated transcription coactivator 2
Gene Type protein-coding
Chromosomal Location 1q21.3
NCBI Gene ID 200186 ncbi.nlm.nih.gov/gene/200186
Ensembl ID ENSG00000143157
UniProt ID Q53ET0
OMIM ID 608972
HGNC ID 25182
Aliases TORC2, MGC138687, MGC138689

Description

CRTC2 (CREB regulated transcription coactivator 2) is a member of the CRTC family of transcriptional coactivators that enhance the activity of CREB (cAMP response element-binding protein). It plays a critical role in gluconeogenesis by promoting the expression of gluconeogenic enzymes in the liver. CRTC2 is regulated by phosphorylation and subcellular localization, and its dysregulation is linked to metabolic disorders such as type 2 diabetes and obesity, as well as certain cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Type 2 Diabetes CRTC2 overactivation increases gluconeogenic gene expression, contributing to hyperglycemia. NCBI Gene, OMIM
Obesity Altered CRTC2 signaling in adipose tissue affects energy balance and insulin sensitivity. NCBI Gene
Hepatocellular Carcinoma CRTC2 overexpression promotes cell proliferation and survival via CREB target genes. COSMIC, NCBI Gene
Colorectal Cancer CRTC2 amplification or overexpression correlates with poor prognosis and metastasis. COSMIC, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Adipose Tissue 8.3 Low
Pancreas 6.1 Low
Kidney 10.2 Medium
Brain 4.7 Low
Heart 3.9 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.8 Liver cancer cell line; high expression
HEK293 9.4 Embryonic kidney; moderate expression
MCF7 7.2 Breast cancer; moderate expression
HeLa 5.6 Cervical cancer; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339Trp) Missense <0.1% Altered phosphorylation and nuclear localization
c.1246G>A (p.Glu416Lys) Missense <0.1% Potential gain-of-function in cancer
c.1570_1571insA Frameshift <0.1% Loss-of-function; truncated protein
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations leading to premature stop codons reduce coactivator activity.

Gain of Function (GOF)

Missense mutations that enhance nuclear localization or CREB binding increase gluconeogenic gene expression.

Dominant Negative (DN)

Not well documented; some truncations may interfere with wild-type CRTC2 function.

Gene Ontology (GO)

• transcription coactivator activity • cAMP response element binding
• regulation of gluconeogenesis • positive regulation of transcription by RNA polymerase II
• nucleus • cytoplasm

Pathways

CREB signaling pathway
Gluconeogenesis
Insulin signaling
cAMP-mediated signaling

Protein Summary

CRTC2 is a 693-amino acid protein that shuttles between the cytoplasm and nucleus. In its dephosphorylated state, it translocates to the nucleus and binds CREB, enhancing transcription of target genes such as PCK1 and G6PC. Phosphorylation by SIK kinases retains it in the cytoplasm. The protein contains a coiled-coil domain for CREB interaction and a nuclear localization signal.

Related Products

Product name Cat.No. Species Gene ID
CRTC2 Knockout HEK293 Cell Line EDJ-KQ788 Human 200186 Details Get a Quote
CRTC2 Knockout HeLa Cell Line EDJ-KQ18350 Human 200186 Details Get a Quote
CRTC2 Knockout A-549 Cell Line EDJ-KQ19498 Human 200186 Details Get a Quote
CRTC2 Knockout HCT 116 Cell Line EDJ-KQ19499 Human 200186 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: